Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

Anti-transcription intermediary factor 1-gamma autoantibody ELISA development and validation.

Aggarwal R, Oddis CV, Goudeau D, Fertig N, Metes I, Stephens C, Qi Z, Koontz D, Levesque MC.

Rheumatology (Oxford). 2014 Mar;53(3):433-7. doi: 10.1093/rheumatology/ket383. Epub 2013 Nov 19.

2.

Anti-signal recognition particle autoantibody ELISA validation and clinical associations.

Aggarwal R, Oddis CV, Goudeau D, Fertig N, Metes I, Stephens C, Qi Z, Koontz D, Levesque MC.

Rheumatology (Oxford). 2015 Jul;54(7):1194-9. doi: 10.1093/rheumatology/keu436. Epub 2014 Dec 17.

3.

Anti-TIF1-γ antibody and cancer-associated myositis: A clinicohistopathologic study.

Hida A, Yamashita T, Hosono Y, Inoue M, Kaida K, Kadoya M, Miwa Y, Yajima N, Maezawa R, Arai S, Kurasawa K, Ito K, Shimada H, Iwanami T, Sonoo M, Hatanaka Y, Murayama S, Uchibori A, Chiba A, Aizawa H, Momoo T, Nakae Y, Sakurai Y, Shiio Y, Hashida H, Yoshizawa T, Sakiyama Y, Oda A, Inoue K, Takeuchi S, Iwata NK, Date H, Masuda N, Mikata T, Motoyoshi Y, Uesaka Y, Maeda MH, Nakashima R, Tsuji S, Kwak S, Mimori T, Shimizu J.

Neurology. 2016 Jul 19;87(3):299-308. doi: 10.1212/WNL.0000000000002863. Epub 2016 Jun 24.

PMID:
27343066
4.

Clinical features of anti-TIF1-α antibody-positive dermatomyositis patients are closely associated with coexistent dermatomyositis-specific autoantibodies and anti-TIF1-γ or anti-Mi-2 autoantibodies.

Muro Y, Ishikawa A, Sugiura K, Akiyama M.

Rheumatology (Oxford). 2012 Aug;51(8):1508-13. doi: 10.1093/rheumatology/kes073. Epub 2012 Apr 25.

PMID:
22539482
5.

Autoantibody levels in myositis patients correlate with clinical response during B cell depletion with rituximab.

Aggarwal R, Oddis CV, Goudeau D, Koontz D, Qi Z, Reed AM, Ascherman DP, Levesque MC.

Rheumatology (Oxford). 2016 Jun;55(6):991-9. doi: 10.1093/rheumatology/kev444. Epub 2016 Feb 16. Erratum in: Rheumatology (Oxford). 2016 Sep;55(9):1710.

PMID:
26888854
6.

Enzyme-linked immunosorbent assays for detection of anti-transcriptional intermediary factor-1 gamma and anti-Mi-2 autoantibodies in dermatomyositis.

Fujimoto M, Murakami A, Kurei S, Okiyama N, Kawakami A, Mishima M, Sato S, Seishima M, Suda T, Mimori T, Takehara K, Kuwana M.

J Dermatol Sci. 2016 Dec;84(3):272-281. doi: 10.1016/j.jdermsci.2016.09.013. Epub 2016 Sep 23.

PMID:
27693019
7.

Anti-MDA5 and anti-TIF1-gamma antibodies have clinical significance for patients with dermatomyositis.

Hoshino K, Muro Y, Sugiura K, Tomita Y, Nakashima R, Mimori T.

Rheumatology (Oxford). 2010 Sep;49(9):1726-33. doi: 10.1093/rheumatology/keq153. Epub 2010 May 25.

PMID:
20501546
8.

Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis.

Ceribelli A, Isailovic N, De Santis M, Generali E, Fredi M, Cavazzana I, Franceschini F, Cantarini L, Satoh M, Selmi C.

Clin Rheumatol. 2017 Feb;36(2):469-475. doi: 10.1007/s10067-016-3453-0. Epub 2016 Oct 20.

PMID:
27761751
9.

Clinical and serological associations of autoantibodies to the Ku70/Ku80 heterodimer determined by a novel chemiluminescent immunoassay.

Mahler M, Swart A, Wu J, Szmyrka-Kaczmarek M, Senécal JL, Troyanov Y, Hanly JG, Fritzler MJ.

Lupus. 2016 Jul;25(8):889-96. doi: 10.1177/0961203316640918.

PMID:
27252266
10.

Rpp25 is a major target of autoantibodies to the Th/To complex as measured by a novel chemiluminescent assay.

Mahler M, Gascon C, Patel S, Ceribelli A, Fritzler MJ, Swart A, Chan EK, Satoh M.

Arthritis Res Ther. 2013 Apr 12;15(2):R50. doi: 10.1186/ar4210.

11.

Anti-TIF1γ antibodies (anti-p155) in adult patients with dermatomyositis: comparison of different diagnostic assays.

Labrador-Horrillo M, Martínez MA, Selva-O'Callaghan A, Trallero-Araguás E, Balada E, Vilardell-Tarrés M, Juarez C.

Ann Rheum Dis. 2012 Jun;71(6):993-6. doi: 10.1136/annrheumdis-2011-200871. Epub 2012 Jan 30.

PMID:
22294626
13.

The multicenter study of a new assay for simultaneous detection of multiple anti-aminoacyl-tRNA synthetases in myositis and interstitial pneumonia.

Nakashima R, Imura Y, Hosono Y, Seto M, Murakami A, Watanabe K, Handa T, Mishima M, Hirakata M, Takeuchi T, Fujio K, Yamamoto K, Kohsaka H, Takasaki Y, Enomoto N, Suda T, Chida K, Hisata S, Nukiwa T, Mimori T.

PLoS One. 2014 Jan 14;9(1):e85062. doi: 10.1371/journal.pone.0085062. eCollection 2014.

14.

A New Immunodot Assay for Multiplex Detection of Autoantibodies in a Cohort of Italian Patients With Idiopathic Inflammatory Myopathies.

Tampoia M, Notarnicola A, Abbracciavento L, Fontana A, Giannini M, Louis Humbel R, Iannone F.

J Clin Lab Anal. 2016 Nov;30(6):859-866. doi: 10.1002/jcla.21948. Epub 2016 Apr 13.

PMID:
27074881
15.

Clinical characteristics of patients with anti-TIF1-γ antibodies.

Masiak A, Kulczycka J, Czuszyńska Z, Zdrojewski Z.

Reumatologia. 2016;54(1):14-8. doi: 10.5114/reum.2016.58756. Epub 2016 Mar 24.

16.

Two young-adult female cases of dermatomyositis with antibodies for transcriptional intermediary factor 1-γ.

Matsuura E, Ishiguro N, Katsumata Y, Urano W, Yamanaka H, Kondo M, Kuwana M, Kaji K, Hamaguchi Y, Fujimoto M, Kawashima M.

Eur J Dermatol. 2012 Sep-Oct;22(5):668-71. doi: 10.1684/ejd.2012.1824.

PMID:
22992252
17.

[Autoantibody profile in myositis].

Allenbach Y, Benveniste O.

Rev Med Interne. 2014 Jul;35(7):437-43. doi: 10.1016/j.revmed.2013.12.006. Epub 2014 Jan 1. Review. French.

18.

Autoantibodies to Su/Argonaute 2 in Japanese patients with inflammatory myopathy.

Ogawa-Momohara M, Muro Y, Satoh M, Akiyama M.

Clin Chim Acta. 2017 Aug;471:304-307. doi: 10.1016/j.cca.2017.06.022. Epub 2017 Jun 30.

PMID:
28673815
19.

Testing for myositis specific autoantibodies: Comparison between line blot and immunoprecipitation assays in 57 myositis sera.

Cavazzana I, Fredi M, Ceribelli A, Mordenti C, Ferrari F, Carabellese N, Tincani A, Satoh M, Franceschini F.

J Immunol Methods. 2016 Jun;433:1-5. doi: 10.1016/j.jim.2016.02.017. Epub 2016 Feb 18.

PMID:
26906088
20.

The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis.

Chinoy H, Fertig N, Oddis CV, Ollier WE, Cooper RG.

Ann Rheum Dis. 2007 Oct;66(10):1345-9. Epub 2007 Mar 28.

Supplemental Content

Support Center